As for psoriasis, IL-17-mediated diseases present dysregulation of this pathway, which plays a crucial role in host defence mechanisms against fungal pathogens, and iatrogenic modification of IL-17 axis could promote alterations of the microbial equilibrium in barrier tissues [7]. Here, IL17A is linked to psoriasis.